Suppr超能文献

胃癌的临床病理危险因素:中国的回顾性队列研究。

Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China.

机构信息

Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China.

School of Life Sciences, University of Science and Technology of China, Hefei, China.

出版信息

BMJ Open. 2019 Sep 20;9(9):e030639. doi: 10.1136/bmjopen-2019-030639.

Abstract

OBJECTIVE

To examine the potential clinicopathological factors affecting the prognosis of patients with gastric cancer after surgical treatment in China.

METHODS

Between 1 January 2001 and 31 December 2012, a total of 716 patients aged 22-84 years with gastric cancer were enrolled in the study. Survival analysis techniques including log rank test and Cox proportional hazard regression model were applied to evaluate the prognostic significance of clinicopathological characteristics in terms of survival time.

RESULTS

Of the 24 demographic and pathological variables collected in the data, 16 prognostic factors of gastric cancer were found to have statistically significant influences on survival time from the unadjusted analyses. The adjusted analysis furtherly revealed that age, age square, lymph node metastasis rate group, tumour size group, surgical type II, number of cancer nodules, invasion depth group and the interaction between surgical type II and tumour size group were important prognosis and clinicopathological factors for gastric cancer in Chinese.

CONCLUSION

Our study with relatively large sample size and many potential risk factors enable us to identify independent risk factors associated with the prognosis of gastric cancer. Findings from the current study can be used to assist clinical decision-making, and serve as a benchmark for the planning of future prognosis and therapy for patients with gastric carcinoma.

摘要

目的

探讨中国胃癌患者手术后预后的潜在临床病理因素。

方法

2001 年 1 月 1 日至 2012 年 12 月 31 日期间,共纳入 716 例年龄为 22-84 岁的胃癌患者。采用生存分析技术,包括对数秩检验和 Cox 比例风险回归模型,评估临床病理特征对生存时间的预后意义。

结果

在收集的 24 个人口统计学和病理学变量中,16 个胃癌预后因素在未经调整的分析中对生存时间有统计学意义的影响。调整分析进一步表明,年龄、年龄平方、淋巴结转移率组、肿瘤大小组、手术类型 II、癌结节数、浸润深度组以及手术类型 II 和肿瘤大小组之间的相互作用是影响中国胃癌预后的重要临床病理因素。

结论

本研究样本量较大,涉及多种潜在危险因素,能够确定与胃癌预后相关的独立危险因素。本研究的结果可用于辅助临床决策,并为未来胃癌患者的预后和治疗计划提供基准。

相似文献

1
Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China.
BMJ Open. 2019 Sep 20;9(9):e030639. doi: 10.1136/bmjopen-2019-030639.
2
[Prognostic factors of lymph node-negative metastasis gastric cancer].
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):190-194.
5
Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.
9
Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
World J Gastroenterol. 2012 Oct 14;18(38):5470-5. doi: 10.3748/wjg.v18.i38.5470.

引用本文的文献

2
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.
Int J Mol Sci. 2024 Feb 3;25(3):1848. doi: 10.3390/ijms25031848.
3
Prediction model of liver metastasis risk in patients with gastric cancer: A population-based study.
Medicine (Baltimore). 2023 Sep 29;102(39):e34702. doi: 10.1097/MD.0000000000034702.
4
Elevation of preoperative serum hs-CRP is an independent risk factor for malnutrition in patients with gastric cancer.
Front Oncol. 2023 May 24;13:1173532. doi: 10.3389/fonc.2023.1173532. eCollection 2023.
5
Genomic analysis of matrix metalloproteinases affecting the prognosis and immunogenic profile of gastric cancer.
Front Genet. 2023 Apr 18;14:1128088. doi: 10.3389/fgene.2023.1128088. eCollection 2023.
6
Significance of Serum Apelin Levels as a Biomarker for Gastric Cancer Diagnosis.
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):827-831. doi: 10.31557/APJCP.2023.24.3.827.
7
PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma.
J Cancer Res Clin Oncol. 2023 Aug;149(10):7139-7153. doi: 10.1007/s00432-023-04607-3. Epub 2023 Mar 8.
9
Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15.
Front Cell Dev Biol. 2022 Mar 31;10:710708. doi: 10.3389/fcell.2022.710708. eCollection 2022.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies.
Can J Gastroenterol Hepatol. 2018 Jun 20;2018:2732408. doi: 10.1155/2018/2732408. eCollection 2018.
4
Cancer statistics in China, 2015.
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
6
Re: variation in surgical-readmission rates and quality of hospital care.
J Urol. 2014 May;191(5):1363-4. doi: 10.1016/j.juro.2014.01.050. Epub 2014 Jan 16.
7
Tumor deposits in gastric carcinomas.
Pathol Res Pract. 2014 Sep;210(9):565-70. doi: 10.1016/j.prp.2014.03.006. Epub 2014 Mar 27.
8
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13. doi: 10.1158/1055-9965.EPI-13-1057. Epub 2014 Mar 11.
9
Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.
World J Gastroenterol. 2013 Oct 21;19(39):6568-78. doi: 10.3748/wjg.v19.i39.6568.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验